PT-141
Bremelanotide
Melanocortin receptor agonist with an FDA-approved indication in premenopausal women; other uses discussed with providers.
Starting at$89/month
Provider Determines Testing
Provider-evaluated therapies related to erectile health.
Melanocortin receptor agonist with an FDA-approved indication in premenopausal women; other uses discussed with providers.
Neuropeptide sometimes discussed for mood, bonding, and intimacy support in provider-directed protocols.
Neuroendocrine peptide studied in hypothalamic-pituitary-gonadal signaling.